Related Experiment Video
Updated: Apr 7, 2026
Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
Published on: March 28, 2025
Patients' attitudes toward melatonin for musculoskeletal pain: Insights for rehabilitation practice
Kangchao Wu1, James Puterflam2, Paula R Beckenkamp1
1School of Health Science, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales (NSW), Australia.
Objective:
To assess the perceptions and attitudes of individuals with chronic MSK pain toward melatonin as a potential treatment for pain management.
Design:
Cross-sectional survey.
Setting:
Nationwide survey conducted via social media platforms and offline advertisements.
Participants:
Adults (≥ 18 years) with chronic MSK pain. A total of 254 individuals completed the survey (mean age 60.8 years; 87 % women).
Methods:
Participants completed a custom-designed survey capturing demographics, pain and sleep disturbances, prior melatonin use, and attitudes toward melatonin for pain and sleep.
Main Outcomes And Measures:
Descriptive statistics of melatonin use, perceived effectiveness, concerns, and willingness to use melatonin for pain management.
Results:
Sleep disturbances were reported by 73 % of participants, with insomnia most common. Forty percent had previously used melatonin, primarily for sleep, yet 57 % of users were uncertain about its analgesic effects. Willingness to use melatonin was expressed by 79 % of users and 83 % of non-users for pain management. General concerns included side effects, drug interactions, efficacy, and cost.
Conclusions:
While less than half of the participants had used melatonin for sleep, there was a positive attitude towards its use as a potential treatment for MSK pain management. Future high-quality randomised controlled trials are needed to assess the effectiveness of melatonin for MSK pain management. CONTRIBUTION OF PAPER.
More Related Videos
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
09:38Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Related Concept Videos
01:19Management of Insomnia
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
01:21Skeletal Muscle Relaxants: Adverse Effects
Unlike...
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
01:23Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...